TWD 21.15
(0.0%)
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2023 | 96.98 Million TWD | 20.13% |
2022 | 80.74 Million TWD | 7.08% |
2021 | 75.4 Million TWD | 11.27% |
2020 | 67.76 Million TWD | 15.58% |
2019 | 58.63 Million TWD | 0.0% |
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2024 Q1 | 20.21 Million TWD | -12.22% |
2024 Q2 | 22.26 Million TWD | 10.12% |
2023 Q1 | 22.54 Million TWD | 6.99% |
2023 Q4 | 23.03 Million TWD | 0.0% |
2023 FY | 96.99 Million TWD | 20.13% |
2023 Q2 | 22.54 Million TWD | 0.0% |
2023 Q3 | 23.03 Million TWD | 2.15% |
2022 Q4 | 21.07 Million TWD | 0.0% |
2022 FY | 80.74 Million TWD | 7.08% |
2022 Q3 | 21.07 Million TWD | 0.0% |
2021 FY | 75.4 Million TWD | 11.27% |
2020 FY | 67.76 Million TWD | 15.58% |
2019 FY | 58.63 Million TWD | 0.0% |
Name | Operating Expenses | Operating Expenses Difference |
---|---|---|
Allied Biotech Corporation | 157.72 Million TWD | 38.512% |
GeneFerm Biotechnology Co., Ltd. | 132.78 Million TWD | 26.964% |
Easywell Biomedicals, Inc. | 333.45 Million TWD | 70.916% |
TTY Biopharm Company Limited | 1.91 Billion TWD | 94.927% |
Synmosa Biopharma Corporation | 1.49 Billion TWD | 93.533% |
Orient EuroPharma Co., Ltd. | 2.14 Billion TWD | 95.483% |
Center Laboratories, Inc. | 697.35 Million TWD | 86.093% |
Tien Liang BioTech Co., Ltd. | 267.27 Million TWD | 63.714% |
Orient Pharma Co., Ltd. | 468.66 Million TWD | 79.307% |
InnoPharmax Inc. | 82.29 Million TWD | -17.845% |
Johnson Chemical Pharmaceutical Works Co., Ltd. | 244.63 Million TWD | 60.356% |
Excelsior Biopharma Inc. | 388.05 Million TWD | 75.008% |
DV Biomed Co., Ltd. | 575.24 Million TWD | 83.141% |
Foresee Pharmaceuticals Co., Ltd. | 1.12 Billion TWD | 91.353% |
Handa Pharmaceuticals, Inc. | 399.14 Million TWD | 75.703% |
UniPharma Co., Ltd. | 78.32 Million TWD | -23.826% |
Anxo Pharmaceutical Co., Ltd. | 396.93 Million TWD | 75.567% |
Alar Pharmaceuticals Inc. | 83.74 Million TWD | -15.806% |
Winston Medical Supply Co., Ltd. | 151.49 Million TWD | 35.984% |
Mercury Biopharmaceutical Corporation | 592 Thousand TWD | -16282.095% |
TSH Biopharm Corporation Limited | 336.26 Million TWD | 71.159% |